Pharmacological Tools to Modulate Autophagy in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Autophagy dysfunction, protein aggregation, and neurodegenerative diseases are interconnected.
• Autophagy is a crucial cellular process for maintaining protein homeostasis (proteostasis).
• Impaired autophagy in neurons leads to aggregate accumulation and neurodegeneration.

Purpose of the Study:

• To review the potential of small molecule modulators of autophagy flux.
• To explore these molecules as potential therapeutic agents for neurodegenerative diseases.

Main Methods:

• Review of existing genetic studies on autophagy and neurodegeneration.
• Analysis of small molecule compounds that modulate autophagy flux.
• Assessment of disease models to evaluate therapeutic efficacy.

Main Results:

• Enhanced autophagy flux promotes cellular and organismal health and extends lifespan.
• Small molecule modulators have demonstrated efficacy in alleviating disease symptoms in neurodegenerative models.
• These molecules represent a promising therapeutic avenue.

Conclusions:

• Small molecules targeting autophagy flux hold significant potential for treating neurodegenerative diseases.
• Further development could lead to the first autophagy-based drugs for these conditions.
• Modulating autophagy offers a viable strategy for combating neurodegenerative disorders.